Home  |  Contact

UniProtKB/Swiss-Prot O75879: Variant p.Phe136Leu

Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial
Gene: GATB
Variant information

Variant position:  136
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  US
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Phenylalanine (F) to Leucine (L) at position 136 (F136L, p.Phe136Leu).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and aromatic (F) to medium size and hydrophobic (L)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In COXPD41; unknown pathological significance.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  136
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  557
The length of the canonical sequence.

Location on the sequence:   VEAAVMTGLALNCHINKKSL  F DRKHYFYADLPAGYQITQQR
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 42 – 557 Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial


Literature citations

Pathogenic variants in glutamyl-tRNAGln amidotransferase subunits cause a lethal mitochondrial cardiomyopathy disorder.
Friederich M.W.; Timal S.; Powell C.A.; Dallabona C.; Kurolap A.; Palacios-Zambrano S.; Bratkovic D.; Derks T.G.J.; Bick D.; Bouman K.; Chatfield K.C.; Damouny-Naoum N.; Dishop M.K.; Falik-Zaccai T.C.; Fares F.; Fedida A.; Ferrero I.; Gallagher R.C.; Garesse R.; Gilberti M.; Gonzalez C.; Gowan K.; Habib C.; Halligan R.K.; Kalfon L.; Knight K.; Lefeber D.; Mamblona L.; Mandel H.; Mory A.; Ottoson J.; Paperna T.; Pruijn G.J.M.; Rebelo-Guiomar P.F.; Saada A.; Sainz B. Jr.; Salvemini H.; Schoots M.H.; Smeitink J.A.; Szukszto M.J.; Ter Horst H.J.; van den Brandt F.; van Spronsen F.J.; Veltman J.A.; Wartchow E.; Wintjes L.T.; Zohar Y.; Fernandez-Moreno M.A.; Baris H.N.; Donnini C.; Minczuk M.; Rodenburg R.J.; Van Hove J.L.K.;
Nat. Commun. 9:4065-4065(2018)
Cited for: INVOLVEMENT IN COXPD41; VARIANT COXPD41 LEU-136; CHARACTERIZATION OF VARIANT COXPD41 LEU-136;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.